Results 211 to 220 of about 4,991,463 (296)

Categorizing differences in postpartum hemorrhage management and associated clinical factors

Pregnancy, Volume 2, Issue 6, November 2026.
Abstract Objective To examine whether there is variation in postpartum hemorrhage (PPH) management and whether differences are associated with patient‐level factors and delivery hospital. Methods This is a retrospective cohort study of patients delivered at ≥20 weeks of gestation at any of four hospitals within one Connecticut healthcare system, with ...
Moeun Son, Lisbet Lundsberg, Caitlin Partridge, Danna Tortal, Heather Burris, Leyla Sahin, Robert Whetsel, Kevin Dysart, Jennifer Culhane   +8 more
wiley   +1 more source

The Influence of Fetal Hemoglobin on Hematological Parameters and Clinical Severity in Patients with Homozygous Sickle Cell Disease. [PDF]

Niger Med J
Talhar SS, Patil BU, Das DK, Ambulkar P, Waghmare JE, Jain J, Jain M, Gangane NM.   +7 more
europepmc   +1 more source

Identifying (Mis)conceptions About Genetic Information: Perspectives of Current and Future Teachers and Psychologists

Mind, Brain, and Education, Volume 20, Issue 4, November 2026.
ABSTRACT Rapid advances in genomics may soon enable low‐cost predictions of children's academic potential. To ensure this knowledge is used responsibly in educational settings, stakeholders require sound genetic literacy. This study assessed genetic knowledge, perceived heritability, and genetic attitudes in preservice teachers (n = 236; 83% female ...
Belinda Wauge, Sally A. Larsen, Brian Byrne   +2 more
wiley   +1 more source

Hair-on-end sign in severe sickle cell disease. [PDF]

Br J Haematol
Neves RDC, de Faria JP, Kjöllerström P.   +2 more
europepmc   +1 more source

Access to Safety Net Programs in the U.S. During the COVID‐19 Pandemic: Barriers and Lessons From a Scoping Review

Social Policy &Administration, Volume 60, Issue 6, Page 1013-1035, November 2026.
ABSTRACT The COVID‐19 pandemic triggered historic expansions of the U.S. social safety net to mitigate unprecedented economic hardship. However, increased government spending and program expansions on paper do not automatically translate into equitable access in practice.
Soohyun Yoon, Jeehae Kang
wiley   +1 more source

Hematopoietic Cell Transplantation for Sickle Cell Disease. [PDF]

Children (Basel)
Guilcher GMT.
europepmc   +1 more source

Improvement of Sickle Cell Disease Care Mitigates the Healthcare Utilization Induced by Increased Prevalence: Experience of a Tertiary Pediatric Center

Pediatric Blood &Cancer, Volume 73, Issue 10, October 2026.
ABSTRACT Background Sickle cell disease (SCD) has undergone major changes in the last decades. Its prevalence has been steadily increasing and numerous advances have been made in the management of the disease. However, the effect in real‐life setting of these major changes is unknown, particularly in a Canadian environment. Procedure We aimed to assess
Maude Cigna, Alexia Muresan, Estelle Lecluze, Karine Leduc, Nathalie Fournier, Maria Tamer, Jean‐François Delisle, Jeremi Charbonneau, Annie Viau, Jessica Darilus, Marie‐Joëlle Doré‐Bergeron, Valérie Arsenault, Evelyne Doyon‐Trottier, Stéphanie Forte, Nancy Robitaille, Yves Pastore, Thomas Pincez   +16 more
wiley   +1 more source

Secretory Phospholipase A2 in Patients With Sickle Cell Disease Hospitalized for Vaso‐Occlusive Pain Episodes

Pediatric Blood &Cancer, Volume 73, Issue 10, October 2026.
ABSTRACT Background Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.
Rawan Korman, Maria Yasmine, Dunia Hatabah, Noor Alzraikat, Frank Harris, Lou Ann Brown, Satheesh Chonat, Nitya Bakshi, Chris A. Rees, Carlton Dampier, Claudia R. Morris   +10 more
wiley   +1 more source

Evaluation of hydroxyurea effect in patients with sickle cell disease: A prospective observational study. [PDF]

Indian J Pharmacol
Battina A, Gajbhiye S, Chindhalore C, Dakhale GN, Bhoyar A, Dube A, Kumbhalkar S, Khushoo V, Juneja R.   +8 more
europepmc   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, Volume 20, Issue 10, Page 2533-2566, October 2026.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source